Security
Bionano Genomics, Inc. Common Stock · BNGO
BNGONASDAQCommon stockCurrentCIK 1411690Updated Nov 3, 2026
Name history
BioNano Genomics, Inc · through Oct 20, 2021Bionano Genomics, Inc · through Oct 20, 2021BioNanomatrix Inc · through Mar 24, 2011
BNGO price & chart
Loading TradingView…
NASDAQ:BNGO on TradingView ↗About the company
We are a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (“OGM”) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research, and for other applications including bioprocessing. We offer a platform-agnostic software solution, which integrates next-generation sequencing (“NGS”), microarray and OGM data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. The Company also offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (“ITP”) technology. Through our Bionano Laboratories business, we also provide OGM-based diagnostic testing services.
In the news
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference ↗
Recent filings
S-3/A filing
S-1 filing
SCHEDULE 13G - filed by HIRSCHMAN ORIN regarding Bionano Genomics, Inc.
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 79,062,000Source | 87,362,000Source | 47,591,000Source | 76,010,000Source | 129,364,000Source | 64,804,000Source | 78,414,000Source | 157,995,000Source | 73,584,000Source | 76,670,000Source | 214,404,000Source | 307,502,000Source |
| Property, Plant and Equipment, NetUSD | 16,172,000Source | 19,995,000Source | 13,017,000Source | 17,264,000Source | 24,863,000Source | 14,040,000Source | 18,339,000Source | 25,279,000Source | 14,847,000Source | 19,219,000Source | 23,345,000Source | 18,029,000Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 77,289,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 5,685,000Source | 11,045,000Source | 1,665,000Source | 7,025,000Source | 30,021,000Source | 3,005,000Source | 8,365,000Source | 31,734,000Source | 4,345,000Source | 9,705,000Source | 33,974,000Source | 41,143,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,065,000Source | 8,794,000Source | 3,730,000Source | 3,562,000Source | 10,425,000Source | 3,425,000Source | 3,625,000Source | 15,759,000Source | 2,990,000Source | 9,173,000Source | 17,948,000Source | 5,091,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 4,526,000Source | 5,316,000Source | 4,366,000Source | 3,493,000Source | 6,255,000Source | 4,133,000Source | 3,354,000Source | 8,313,000Source | 5,200,000Source | 4,752,000Source | 9,319,000Source | 7,022,000Source |
| Inventory, NetUSD | 8,424,000Source | 16,281,000Source | 7,015,000Source | 10,308,000Source | 23,149,000Source | 7,688,000Source | 11,417,000Source | 23,802,000Source | 7,828,000Source | 13,276,000Source | 27,602,000Source | 29,761,000Source |
| Assets, CurrentUSD | 48,800,000Source | 46,980,000Source | 24,878,000Source | 42,662,000Source | 60,568,000Source | 38,975,000Source | 44,929,000Source | 85,611,000Source | 45,386,000Source | 39,489,000Source | 140,118,000Source | 157,298,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 5,378,000Source | 4,387,000Source | 4,890,000Source | 3,098,000Source | 4,889,000Source | 4,864,000Source | 2,782,000Source | 4,945,000Source | 5,203,000Source | 3,141,000Source | 6,019,000Source | 7,329,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,497,000Source | 2,833,000Source | 2,935,000Source | 3,772,000Source | 4,221,000Source | 3,062,000Source | 1,108,000Source | 4,870,000Source | 3,217,000Source | 1,804,000Source | 5,633,000Source | 7,222,000Source |
| Other Assets, NoncurrentUSD | 1,762,000Source | 2,758,000Source | 2,103,000Source | 2,089,000Source | 5,889,000Source | 2,678,000Source | 2,424,000Source | 6,648,000Source | 2,694,000Source | 2,754,000Source | 7,431,000Source | 2,414,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 29,263,000Source | 38,494,000Source | 15,985,000Source | 30,636,000Source | 49,027,000Source | 27,341,000Source | 30,226,000Source | 75,224,000Source | 29,160,000Source | 41,295,000Source | 118,247,000Source | 58,104,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,000Source | 9,000Source | 1,000Source | 0Source | 7,000Source | 1,000Source | 0Source | 6,000Source | 1,000Source | 0Source | 5,000Source | 30,000Source |
| Retained Earnings (Accumulated Deficit)USD | -711,687,000Source | -673,100,000Source | -735,346,000Source | -703,184,000Source | -628,854,000Source | -727,923,000Source | -696,327,000Source | -612,630,000Source | -719,620,000Source | -693,225,000Source | -581,208,000Source | -348,715,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 6,000Source | 1,534,000Source | 14,000Source | -10,000Source | -3,000Source | 12,000Source | 14,000Source | -16,000Source | 17,000Source | 27,000Source | 23,000Source | -1,124,000Source |
| Stockholders' Equity Attributable to ParentUSD | 49,799,000Source | 48,864,000Source | 31,606,000Source | 45,374,000Source | 80,335,000Source | 37,463,000Source | 48,188,000Source | 82,770,000Source | 44,424,000Source | 35,375,000Source | 96,157,000Source | 249,398,000Source |
| Additional Paid in Capital, Common StockUSD | 761,479,000Source | 720,425,000Source | 766,937,000Source | 748,568,000Source | 709,187,000Source | 765,373,000Source | 744,501,000Source | 695,411,000Source | 764,026,000Source | 728,573,000Source | 677,337,000Source | 599,207,000Source |
| Liabilities and EquityUSD | 79,062,000Source | 87,362,000Source | 47,591,000Source | 76,010,000Source | 129,364,000Source | 64,804,000Source | 78,414,000Source | 157,995,000Source | 73,584,000Source | 76,670,000Source | 214,404,000Source | 307,502,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 22,977,000Source | 32,950,000Source | 10,039,000Source | 24,178,000Source | 37,175,000Source | 21,228,000Source | 26,408,000Source | 58,506,000Source | 22,942,000Source | 37,344,000Source | 100,028,000Source | 35,884,000Source |
| Operating Lease, Liability, CurrentUSD | 1,025,000Source | 1,956,000Source | 633,000Source | 1,348,000Source | 2,139,000Source | 646,000Source | 1,592,000Source | 2,190,000Source | 697,000Source | 2,991,000Source | 2,163,000Source | 2,260,000Source |
| Accounts Payable, CurrentUSD | 5,990,000Source | 8,700,000Source | 4,562,000Source | 6,244,000Source | 8,734,000Source | 5,062,000Source | 6,562,000Source | 9,844,000Source | 5,590,000Source | 6,962,000Source | 10,384,000Source | 12,534,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,599,000Source | 1,730,000Source | 2,384,000Source | 2,704,000Source | 2,242,000Source | 2,507,000Source | 0Source | 2,755,000Source | 2,489,000Source | 145,000Source | 3,590,000Source | 5,504,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 4,706,000Source | 5,883,000Source | 3,456,000Source | 3,405,000Source | 5,530,000Source | 3,996,000Source | 3,937,000Source | 11,028,000Source | 5,460,000Source | 5,641,000Source | 8,089,000Source | 10,552,000Source |
| Deferred Revenue, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 871,000Source |
| Deferred Revenue, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 127,000Source |
| Restricted Cash and Investments, Current | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -132,596,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 2,310,000Source | 2,434,000Source | 9,527,000Source | 14,022,000Source | 13,708,000Source | 9,621,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 670,000Source | 1,587,000Source | 4,534,000Source | 9,736,000Source | 15,178,000Source | 22,417,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,067,000Source | -1,398,000Source | 448,000Source | -4,139,000Source | 2,296,000Source | 2,900,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 106,000Source | -1,110,000Source | -4,916,000Source | 587,000Source | 4,150,000Source | 23,676,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -528,000Source | -401,000Source | -1,372,000Source | -3,420,000Source | -1,995,000Source | 1,949,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 1,760,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -5,716,000Source | -2,764,000Source | -16,345,000Source | -68,922,000Source | -125,181,000Source | -124,816,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 5,457,000Source | -14,066,000Source | -12,747,000Source | 73,839,000Source | 24,158,000Source | 82,767,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 657,000Source | 10,891,000Source | 24,039,000Source | -13,685,000Source | 113,815,000Source | 23,007,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 403,000Source | -5,948,000Source | -5,064,000Source | -8,775,000Source | 12,857,000Source | -19,080,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 3,065,000Source | 9,194,000Source | 4,231,000Source | 3,562,000Source | 4,912,000Source | 3,625,000Source | 4,509,000Source | 9,573,000Source | 18,348,000Source | 5,491,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 355,000Source | 479,000Source | 1,674,000Source | 10,653,000Source | 1,648,000Source | 298,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 119,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 5,000Source | -9,000Source | -11,000Source | -7,000Source | 65,000Source | -38,000Source |
| Additional Financial Items | ||||||||||||
| Accretion ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 638,000Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 941,000Source | 2,202,000Source | 970,000Source | 1,080,000Source | 670,000Source | 1,587,000Source | 4,534,000Source | 9,736,000Source | 15,178,000Source | 22,417,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | 0Source | 0Source | — | 0Source | — | — | 0Source | 1,747,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 5,400,000Source | 6,600,000Source | 7,200,000Source | 5,800,000Source |
| DepreciationUSD | — | — | — | — | 1,000,000Source | 1,000,000Source | 1,000,000Source | 1,100,000Source | 4,200,000Source | 4,900,000Source | 6,500,000Source | 3,800,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | -1,400,000Source | — | — | -34,000Source | -19,000Source | -258,000Source | -1,404,000Source | — | — |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | 400,000Source | — | 400,000Source | 400,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source | — | 0Source | — | — | 0Source | 3,965,000Source | — | 0Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 77,289,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 77,280,000Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 14,000Source | 24,000Source | 7,000Source | 10,000Source | 10,000Source | 7,000Source | 67,000Source | 33,000Source | 62,000Source | 1,884,000Source |
| Inventory Write-downUSD | — | — | — | 7,200,000Source | — | — | — | — | 0Source | 7,231,000Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 1,000,000Source | 1,500,000Source | 3,300,000Source | 1,500,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -8,503,000Source | -44,246,000Source | -7,423,000Source | -6,857,000Source | -8,303,000Source | -3,102,000Source | -26,395,000Source | -112,017,000Source | -232,493,000Source | -132,596,000Source |
| Nonoperating Income (Expense)USD | — | — | 49,000Source | -321,000Source | -198,000Source | 953,000Source | -396,000Source | 5,370,000Source | 7,011,000Source | -8,001,000Source | -17,186,000Source | 986,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 3,754,000Source | 3,778,000Source | 3,024,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 1,407,000Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -219,000Source | -697,000Source | -344,000Source | 676,000Source | -619,000Source | 5,080,000Source | 5,900,000Source | -10,102,000Source | 3,449,000Source | -223,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 705,000Source | 13,317,000Source | 31,098,000Source | 44,433,000Source | 57,697,000Source | — |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | 0Source | 0Source | -14,000Source | -23,000Source | -66,000Source |
| Restructuring CostsUSD | — | — | 0Source | 1,770,000Source | — | 0Source | — | 0Source | 0Source | 8,022,000Source | — | — |
| Restricted Cash and Investments, Current | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 7,367,000Source | 6,073,000Source | 8,171,000Source | 6,733,000Source | 6,687,000Source | 6,457,000Source | 28,508,000Source | 30,776,000Source | 36,116,000Source | 27,802,000Source |
| Cost of RevenueUSD | — | — | 3,997,000Source | 14,519,000Source | 3,857,000Source | 3,256,000Source | 3,435,000Source | 3,519,000Source | 15,323,000Source | 30,396,000Source | 26,550,000Source | 21,857,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 9,064,000Source | 9,464,000Source | 8,544,000Source | 8,346,000Source | 8,010,000Source | 9,033,000Source | 35,150,000Source | 51,855,000Source | 93,499,000Source | 88,596,000Source |
| Operating Income (Loss)USD | — | — | -8,538,000Source | -43,901,000Source | -7,218,000Source | -7,800,000Source | -7,897,000Source | -8,465,000Source | -33,339,000Source | -103,983,000Source | -215,245,000Source | -131,698,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -219,000Source | -697,000Source | -344,000Source | 676,000Source | -619,000Source | 5,080,000Source | 5,900,000Source | -10,102,000Source | 3,449,000Source | -223,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -8,489,000Source | -44,222,000Source | -7,416,000Source | -6,847,000Source | -8,293,000Source | -3,095,000Source | -26,328,000Source | -111,984,000Source | -232,431,000Source | -130,712,000Source |
| Income Tax Expense (Benefit)USD | — | — | 14,000Source | 24,000Source | 7,000Source | 10,000Source | 10,000Source | 7,000Source | 67,000Source | 33,000Source | 62,000Source | 1,884,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -8,503,000Source | -44,246,000Source | -7,423,000Source | -6,857,000Source | -8,303,000Source | -3,102,000Source | -26,395,000Source | -112,017,000Source | -232,493,000Source | -132,596,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.59Source | -30.92Source | -0.64Source | -1.99Source | -0.76Source | -1.15Source | -4.85Source | -88.13Source | -6.81Source | -0.46Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.59Source | -30.92Source | -0.64Source | -1.99Source | -0.76Source | -1.15Source | -4.85Source | -88.13Source | -6.81Source | -0.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 5,338,000Source | 1,431,000Source | 11,546,000Source | 3,441,000Source | 10,979,000Source | 2,694,000Source | 5,445,000Source | 1,271,000Source | 34,150,000Source | 289,210,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 5,338,000Source | 1,431,000Source | 11,546,000Source | 3,441,000Source | 10,979,000Source | 2,694,000Source | 5,445,000Source | 1,271,000Source | 34,150,000Source | 289,210,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 5,400,000Source | 6,600,000Source | 7,200,000Source | 5,800,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 1,800,000Source |
| Costs and ExpensesUSD | — | — | 11,908,000Source | 35,455,000Source | 11,532,000Source | 11,277,000Source | 11,149,000Source | 11,403,000Source | 46,524,000Source | 104,363,000Source | 224,811,000Source | 137,643,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 67,000Source | 33,000Source | 62,000Source | 124,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 77,280,000Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -26,450,000Source | -112,422,000Source | -235,852,000Source | -131,237,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 5,119,000Source | 298,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 268,000Source | 376,000Source | 146,000Source | 277,000Source | 223,000Source | 290,000Source | 1,111,000Source | 2,101,000Source | 3,311,000Source | 1,507,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 1,000,000Source | 1,500,000Source | 3,300,000Source | 1,500,000Source |
| Nonoperating Income (Expense)USD | — | — | 49,000Source | -321,000Source | -198,000Source | 953,000Source | -396,000Source | 5,370,000Source | 7,011,000Source | -8,001,000Source | -17,186,000Source | 986,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 2,500,000Source | 3,754,000Source | 3,778,000Source | 3,024,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | 0Source | 0Source | -14,000Source | -23,000Source | -66,000Source |
| Research and Development ExpenseUSD | — | — | 2,844,000Source | 4,717,000Source | 2,988,000Source | 2,931,000Source | 3,139,000Source | 2,370,000Source | 11,374,000Source | 24,803,000Source | 54,032,000Source | 49,047,000Source |
| Restructuring and Related Cost, Incurred CostUSD | — | — | — | — | — | — | 200,000Source | — | 300,000Source | 600,000Source | — | — |
| Restructuring CostsUSD | — | — | 0Source | 1,770,000Source | — | 0Source | — | 0Source | 0Source | 8,022,000Source | — | — |
Offerings
Registration 333-295699
Registration 333-299660
Registration 333-290187
- Gross proceeds
- 9999992.5
- Net proceeds
- 9399992.5
- Deal price
- 2.0
- Shares
- 4999996
- Offering amount
- $...
- Offering price
- $2.00
- Ticker
- BNGO
Filing attachments
bngo-ex99_1.htm · 8-K · 2026-09-14
EX-99.1 2 bngo-ex99_1.htm EX-99.1 September 14, 2026 Albert Luderer, PhD Chairman and Interim CEO Bionano This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of mana…
Read attachment ↗bngo-ex99_1.htm · 8-K · 2026-08-10
EX-99.1 2 bngo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Bionano Reports Second Quarter 2026 Results and Provides a Business Update Conference call today, August 10, 2026, at 4:30 PM ET SAN DIEGO, August 10, 2026 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2026. “Our second quarter results reflect a strong vote of confidence from our routine use customer community and the accelerating global adoption of op…
Read attachment ↗bngo-ex99_1.htm · 8-K · 2026-06-24
EX-99.1 2 bngo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Bionano Announces Hiring of Chief Scientific Officer San Diego, June 24, 2026 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph. D., as its Chief Scientific Officer (CSO), effective July 20, 2026. In this role, Dr. Hastie will lead the company’s global scientific strategy, innovation roadmap, and research initiatives, advancing Bionano’s …
Read attachment ↗bngo-ex99_1.htm · 8-K · 2026-05-28
EX-99.1 2 bngo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the “Debentures”). The Company used cash on hand to retire the Debentures, which were originally issued in May 2024 in the aggregate face value of $20,000,000.…
Read attachment ↗bngo-ex99_1.htm · 8-K · 2026-05-13
EX-99.1 2 bngo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Bionano Reports First Quarter 2026 Results and Provides a Business Update Conference call today, May 13, 2026, at 4:30 PM ET SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. “The Bionano business is healthy, with first quarter results reflecting the continued engagement of our installed base and positive utilization trends ac…
Read attachment ↗bngo-ex4_18.htm · S-3 · 2026-05-08
Exhibit 4.18 BIONANO GENOMICS, INC. and Trustee INDENTURE Dated as of SENIOR DEBT SECURITIES IF " DOCVARIABLE "SWDocIDLocation" 1" = "1" " DOCPROPERTY "SWDocID" 328292035v1" "" 328292035v1 CROSS-REFERENCE TABLE(1) Section of Section of Trust Indenture Act Indenture of 1939, as amended ────────────────────────────────────────── 310(a) 6.09 310(b) 6.08 6.10 …
Read attachment ↗